The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Nowadays, immune checkpoint inhibitors (ICIs) have become one of the essential immunotherapies for cancer patients. However, the impact of antibiotic (ATB) use on cancer patients treated with ICIs remains controversial. METHODS: Our research included retrospective studies and a randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiaxin, Huang, Guowei, Wong, Wan-Ching, Hu, Da-hai, Zhu, Jie-wen, Li, Ruiman, Zhou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367677/
https://www.ncbi.nlm.nih.gov/pubmed/35967438
http://dx.doi.org/10.3389/fimmu.2022.968729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367677/
https://www.ncbi.nlm.nih.gov/pubmed/35967438
http://dx.doi.org/10.3389/fimmu.2022.968729

Ejemplares similares